Gene-Chemical Interaction Annotations Click to see Annotation Detail View
Term | Qualifier | Evidence | With | Reference | Notes | Source | Original Reference(s) | 1,2-dimethylhydrazine | decreases expression | ISO | Prrg3 (Mus musculus) | 6480464 | 1 and 2-Dimethylhydrazine results in decreased expression of PRRG3 mRNA | CTD | PMID:22206623 | 2,2',4,4',5,5'-hexachlorobiphenyl | multiple interactions | ISO | Prrg3 (Mus musculus) | 6480464 | [2 more ... | CTD | PMID:25510870 | 2,2',5,5'-tetrachlorobiphenyl | multiple interactions | ISO | Prrg3 (Mus musculus) | 6480464 | [2 more ... | CTD | PMID:25510870 | 2-palmitoylglycerol | increases expression | EXP | | 6480464 | 2-palmitoylglycerol results in increased expression of PRRG3 mRNA | CTD | PMID:37199045 | 3-isobutyl-1-methyl-7H-xanthine | multiple interactions | EXP | | 6480464 | [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in decreased expression of PRRG3 mRNA | CTD | PMID:28628672 | 4-hydroxyphenyl retinamide | decreases expression | ISO | Prrg3 (Mus musculus) | 6480464 | Fenretinide results in decreased expression of PRRG3 mRNA | CTD | PMID:28973697 | acrylamide | decreases expression | EXP | | 6480464 | Acrylamide results in decreased expression of PRRG3 mRNA | CTD | PMID:32763439 | antirheumatic drug | increases expression | EXP | | 6480464 | Antirheumatic Agents results in increased expression of PRRG3 mRNA | CTD | PMID:24449571 | benzo[a]pyrene | multiple interactions | ISO | Prrg3 (Mus musculus) | 6480464 | [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of PRRG3 mRNA | CTD | PMID:27858113 | benzo[a]pyrene | decreases methylation | EXP | | 6480464 | Benzo(a)pyrene results in decreased methylation of PRRG3 5' UTR | CTD | PMID:27901495 | benzo[a]pyrene | increases expression | ISO | Prrg3 (Mus musculus) | 6480464 | Benzo(a)pyrene results in increased expression of PRRG3 mRNA | CTD | PMID:32417428 | benzo[a]pyrene | affects methylation | EXP | | 6480464 | Benzo(a)pyrene affects the methylation of PRRG3 promoter | CTD | PMID:27901495 | benzo[b]fluoranthene | multiple interactions | ISO | Prrg3 (Mus musculus) | 6480464 | [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of PRRG3 mRNA | CTD | PMID:27858113 | bisphenol A | decreases expression | ISO | Prrg3 (Rattus norvegicus) | 6480464 | bisphenol A results in decreased expression of PRRG3 mRNA | CTD | PMID:25181051 | bisphenol A | multiple interactions | ISO | Prrg3 (Rattus norvegicus) | 6480464 | [bisphenol A co-treated with tributyltin] results in decreased expression of PRRG3 mRNA | CTD | PMID:31129395 | bisphenol F | multiple interactions | EXP | | 6480464 | [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in decreased expression of PRRG3 mRNA | CTD | PMID:28628672 | carbon nanotube | increases expression | ISO | Prrg3 (Mus musculus) | 6480464 | Nanotubes more ... | CTD | PMID:25554681 | CGP 52608 | multiple interactions | EXP | | 6480464 | CGP 52608 promotes the reaction [RORA protein binds to PRRG3 gene] | CTD | PMID:28238834 | chlordecone | increases expression | ISO | Prrg3 (Mus musculus) | 6480464 | Chlordecone results in increased expression of PRRG3 mRNA | CTD | PMID:33711761 | chloroprene | increases expression | ISO | Prrg3 (Mus musculus) | 6480464 | Chloroprene results in increased expression of PRRG3 mRNA | CTD | PMID:23125180 | chrysene | multiple interactions | ISO | Prrg3 (Mus musculus) | 6480464 | [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of PRRG3 mRNA | CTD | PMID:27858113 | dexamethasone | multiple interactions | EXP | | 6480464 | [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in decreased expression of PRRG3 mRNA | CTD | PMID:28628672 | dibenz[a,h]anthracene | increases expression | ISO | Prrg3 (Mus musculus) | 6480464 | 1 more ... | CTD | PMID:26377693 | dorsomorphin | multiple interactions | EXP | | 6480464 | [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of PRRG3 mRNA | CTD | PMID:27188386 | folic acid | decreases expression | ISO | Prrg3 (Mus musculus) | 6480464 | Folic Acid results in decreased expression of PRRG3 mRNA | CTD | PMID:25629700 | indometacin | multiple interactions | EXP | | 6480464 | [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in decreased expression of PRRG3 mRNA | CTD | PMID:28628672 | nickel atom | decreases expression | EXP | | 6480464 | Nickel results in decreased expression of PRRG3 mRNA | CTD | PMID:25583101 | ozone | decreases expression | ISO | Prrg3 (Rattus norvegicus) | 6480464 | Ozone results in decreased expression of PRRG3 mRNA | CTD | PMID:28623178 | paraquat | decreases expression | ISO | Prrg3 (Rattus norvegicus) | 6480464 | Paraquat results in decreased expression of PRRG3 mRNA | CTD | PMID:32680482 | PCB138 | multiple interactions | ISO | Prrg3 (Mus musculus) | 6480464 | [2 more ... | CTD | PMID:25510870 | SB 431542 | multiple interactions | EXP | | 6480464 | [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of PRRG3 mRNA | CTD | PMID:27188386 | sodium arsenite | increases expression | EXP | | 6480464 | sodium arsenite results in increased expression of PRRG3 mRNA | CTD | PMID:29301061 | sunitinib | decreases expression | EXP | | 6480464 | Sunitinib results in decreased expression of PRRG3 mRNA | CTD | PMID:31533062 | tetrachloromethane | affects expression | ISO | Prrg3 (Mus musculus) | 6480464 | Carbon Tetrachloride affects the expression of PRRG3 mRNA | CTD | PMID:17484886 | tetraphene | multiple interactions | ISO | Prrg3 (Mus musculus) | 6480464 | [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of PRRG3 mRNA | CTD | PMID:27858113 | tributylstannane | multiple interactions | ISO | Prrg3 (Rattus norvegicus) | 6480464 | [bisphenol A co-treated with tributyltin] results in decreased expression of PRRG3 mRNA | CTD | PMID:31129395 | valproic acid | increases methylation | EXP | | 6480464 | Valproic Acid results in increased methylation of PRRG3 gene | CTD | PMID:29154799 | valproic acid | decreases expression | EXP | | 6480464 | Valproic Acid results in decreased expression of PRRG3 mRNA | CTD | PMID:23179753 and PMID:26272509 | valproic acid | multiple interactions | EXP | | 6480464 | [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of PRRG3 mRNA | CTD | PMID:27188386 | vorinostat | decreases expression | EXP | | 6480464 | vorinostat results in decreased expression of PRRG3 mRNA | CTD | PMID:27188386 | |